NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 83 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $506,010 | +92916.5% | 609,651 | -21.6% | 0.00% | – |
| Q1 2023 | $544 | -32.7% | 777,148 | -51.0% | 0.00% | – |
| Q4 2022 | $808 | -99.9% | 1,587,267 | -6.4% | 0.00% | -100.0% |
| Q3 2022 | $1,085,000 | -50.2% | 1,695,383 | -19.9% | 0.00% | 0.0% |
| Q2 2022 | $2,180,000 | -6.2% | 2,116,143 | +71.2% | 0.00% | 0.0% |
| Q1 2022 | $2,323,000 | -46.7% | 1,235,707 | +36.7% | 0.00% | -50.0% |
| Q4 2021 | $4,356,000 | +114.8% | 903,660 | +222.1% | 0.00% | +100.0% |
| Q3 2021 | $2,028,000 | +39.1% | 280,517 | +77.6% | 0.00% | 0.0% |
| Q2 2021 | $1,458,000 | -19.1% | 157,971 | +7.9% | 0.00% | 0.0% |
| Q1 2021 | $1,802,000 | -10.6% | 146,349 | +2.4% | 0.00% | 0.0% |
| Q4 2020 | $2,015,000 | +152.2% | 142,898 | +114.7% | 0.00% | 0.0% |
| Q3 2020 | $799,000 | -76.1% | 66,565 | -67.0% | 0.00% | -80.0% |
| Q2 2020 | $3,348,000 | -60.9% | 201,671 | -73.2% | 0.01% | -73.7% |
| Q1 2020 | $8,568,000 | +1359.6% | 752,941 | +1480.3% | 0.02% | +1800.0% |
| Q4 2019 | $587,000 | -49.7% | 47,644 | -88.4% | 0.00% | -50.0% |
| Q3 2019 | $1,166,000 | – | 409,203 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |